|
Program Overview
The course summarizes epidemiological data on renal cancer as well
as clinical presentations and diagnostic tools as well as the modern
imaging methods as MRI. Standard (surgical) treatment of renal cancer
is detailed. Anatomy of both kidneys and different surgical approaches
are described. NSS for renal cancer is treated. Laparoscopic, radical
and partial nephrectomy are extensively treated. Clinical cases are
used to give practical examples of course topics.
Learning Objectives
After completing the course, users should be able to:
- Diagnose Renal Cell Carcinoma (RCC) based on epidemiological data
on renal cancer as well as clinical presentations and diagnostic tools.
- Understand, describe and debate the different surgical treatments
of RCC including radical nephrectomy, nephron sparing surgery (NSS)
and laparoscopy.
Physician Participation in the Learning Process
Please follow these steps in order to receive CME credit for
viewing the webcast:
- Read the ABOUT CME information
- Complete the online registration
- View the complete course programme
- Complete the online evaluation
- Submit your application for credits
Only those hours actually spent on this educational activity should
be claimed for CME credit.
Estimated Time to Complete the Educational
Activity
Eight session of two hours each, i.e. 16 hours in total. We recommend
that you complete the course within eight weeks of starting.
CME applicants may complete the course in any order and over an extended
period of time. Progress through the program will be tracked and recorded,
so applicants may view portions of the course, take a break, and return
at a later time to complete the test. Tests will be graded online, and
results will be displayed immediately.
Date of Release
March 12, 2003.
Price
No charge
Disclosure
It is the policy of European Board of Urology to ensure objectivity,
balance, independence and a high scientific standard of educational
events that receive accreditation. All speakers/chairpersons participating
must disclose all potential or perceived conflicts of interest that
might introduce bias in the presentation.
The existence of potential conflicts of interest does not necessarily
indicate a bias. However, it is our ethical obligation to inform organizers
and participants so that they are aware of any relationship that may
cause unintentional bias. A potential conflict of interest may arise
from various relationships, past or present, such as employment, consultancy,
investments and stock ownership, funding for research, family relationship
etc..
Ziya Kirkali
Dokuz Eylül University
School of Medicine
Department of Urology
Izmir, Turkey
|
Nothing to disclose |
Didier Jacqmin
Hôpital Civil
Service d'Urologie
Strasbourg, France
|
|
Gerald H.J. Mickisch
Department of Urology
Erasmus University & Academic Hospital
Rotterdam, The Netherlands
|
|
Hein Van Poppel, MD, PhD, FEBU
Professor in Urologic Oncology
University Hospital Gasthuisberg
Katholieke Universiteit Leuven, Belgium
|
Nothing to disclose |
| M. Pilar Laguna |
Nothing to disclose |
| Henk van der Poel |
Nothing to disclose |
Evaluation
Those applying for CME credits must first evaluate the course before
their credits can be issued.
Click here for EVALUATION.
Apply for Credits
Once you have completed and evaluated the course, you can apply for
your credits. Write to eau@prous.com
|